Characteristics of an Environmentally Monitored Prolonged Type 2 Vaccine Derived Poliovirus Shedding Episode that Stopped without Intervention

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Hovi, Tapani ^a   Paananen, Anja ^a   Blomqvist, Soile ^a   Savolainen Kopra, Carita ^a   Al Hello, Haider ^a   Smura, Teemu ^a   Shimizu, Hiroyuki ^b   Nadova, Katarina ^c   Sobotova, Zdenka ^d   Gavrilin, Eugene ^e   Roivainen, Merja ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c Health Centre Municipality of Skalica   (Slovakia)

^d Public Health Authority of the Slovak Republic   (Slovakia)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHENOTYPE; PHYLOGENY; POLIOMYELITIS VIRUS; POLIOMYELITIS VIRUS 2; SEASONAL VARIATION; SEWAGE; SLOVAKIA; VIRUS CULTURE; VIRUS DETECTION; VIRUS GENOME; VIRUS ISOLATION; VIRUS SHEDDING; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CHILD; ENVIRONMENTAL MICROBIOLOGY; GENETIC VARIATION; HUMANS; MICE; MICE, TRANSGENIC; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; PROTEIN MULTIMERIZATION; SEASONS; SEQUENCE HOMOLOGY, AMINO ACID; SEWAGE; SLOVAKIA; VACCINATION;

EID: 84879549263     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066849     Document Type: Article

References (33)

1. Minor P, (2009) Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication. Vaccine 27: 2649-2652.
2. Nkowane BM, Wassilak SG, Orenstein WA, Bart KJ, Schonberger LB, et al. (1987) Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA 257: 1335-1340.
3. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA, (2005) Vaccine-Derived Polioviruses and the Endgame Strategy for Global Polio Eradication (*). Annu Rev Microbiol 59: 587-635.
4. Martin J, (2006) Vaccine-derived poliovirus from long term excretors and the end game of polio eradication. Biologicals 34: 117-122.
5. Vinje J, Gregoricus N, Martin J, Gary HE Jr, Caceres VM, et al. (2004) Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola. J Infect Dis 189: 1168-1175.
6. Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, et al. (2002) Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296: 356-359.
7. Blomqvist S, Savolainen C, Laine P, Hirttio P, Lamminsalo E, et al. (2004) Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia. J Virol 78: 4876-4883.
8. Roivainen M, Blomqvist S, Al-Hello H, Paananen A, Delpeyroux F, et al. (2010) Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage. Euro Surveill 15: pii/19566.
9. Shulman LM, Manor Y, Sofer D, Handsher R, Swartz T, et al. (2006) Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations. PLoS One 1: e69.
10. Shulman LM, Manor Y, Handsher R, Delpeyroux F, McDonough MJ, et al. (2000) Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J Clin Microbiol 38: 3729-3734.
11. Cernakova B, Sobotova Z, Rovny I, Blahova S, Roivainen M, et al. (2005) Isolation of vaccine-derived polioviruses in the Slovak Republic. Eur J Clin Microbiol Infect Dis 24: 438-439.
12. WHO (2003) Guidelines for environmental surveillance of poliovirus circulation. Dept of Vaccines and Biologicals WHO webpage: http://whqlibdoc.who.int/hq/2003/WHO_V&B_03.03.pdf, last accessed 20 May 2013.
13. Poyry T, Stenvik M, Hovi T, (1988) Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland. Appl Environ Microbiol 54: 371-374.
14. van der Avoort HG, Hull BP, Hovi T, Pallansch MA, Kew OM, et al. (1995) Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol 33: 2562-2566.
15. Shimizu H, Thorley B, Paladin FJ, Brussen KA, Stambos V, et al. (2004) Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol 78: 13512-13521.
16. Blomqvist S, Bruu AL, Stenvik M, Hovi T, (2003) Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. J Gen Virol 84: 573-580.
17. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
18. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: Molecular Evolutionary Genetics Analysis using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol 28: 2731-2739.
19. MacLennan C, Dunn G, Huissoon AP, Kumararatne DS, Martin J, et al. (2004) Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 363: 1509-1513.
20. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, et al. (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73: 152-160.
21. Salminen MO, Carr JK, Burke DS, McCutchan FE, (1995) Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 11: 1423-1425.
22. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ, (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
23. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG, (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25: 4876-4882.
24. Lentz KN, Smith AD, Geisler SC, Cox S, Buontempo P, et al. (1997) Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes. Structure 5: 961-978.
25. Jmol Jmol: an open-source Java viewer for chemical structures in 3D. Available: http://www.jmol.org/. Accessed 2013 April 5.
26. Goodfellow I, Chaudhry Y, Richardson A, Meredith J, Almond JW, et al. (2000) Identification of a cis-acting replication element within the poliovirus coding region. J Virol 74: 4590-4600.
27. Halsey NA, Pinto J, Espinosa-Rosales F, Faure-Fontenla MA, da Silva E, et al. (2004) Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. Bull World Health Organ 82: 3-8.
28. Thibaut HJ, De Palma AM, Neyts J, (2012) Combating enterovirus replication: state-of-the-art on antiviral research. Biochem Pharmacol 83: 185-192.
29. Hovi T, Stenvik M, Partanen H, Kangas A, (2001) Poliovirus surveillance by examining sewage specimens. Quantitative recovery of virus after introduction into sewerage at remote upstream location. Epidemiol Infect 127: 101-106.
30. Kinnunen L, Poyry T, Hovi T, (1991) Generation of virus genetic lineages during an outbreak of poliomyelitis. J Gen Virol 72 (Pt 10) (): 2483-2489.
31. Odoom JK, Yunus Z, Dunn G, Minor PD, Martin J, (2008) Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient. J Virol 82: 9179-9190.
32. Martin J, Dunn G, Hull R, Patel V, Minor PD, (2000) Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol 74: 3001-3010.
33. Dowdle W, van der Avoort H, de Gourville E, Delpeyroux F, Desphande J, et al. (2006) Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management. Risk Anal 26: 1449-1469.